[1]
Abdallah Marey Aboshhran, Saeed Ali Alqahtani, Yasser Mesfer Alqhtani, Ahmed Saleh Alharthi, Abdulrahman Hussain Fawwaz Kahl and Khaled Mohsin Ismail Khormi 2023. PUBLIC INTEREST IN THE OFF-LABEL USE OF GLUCAGON-LIKE PEPTIDE 1 AGONISTS (OZEMPIC) FOR COSMETIC WEIGHT LOSS‏. Journal of Population Therapeutics and Clinical Pharmacology. 30, 2 (Feb. 2023), 745–747. DOI:https://doi.org/10.53555/jptcp.v30i2.4746.